NCT05977998View on ClinicalTrials.gov

A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 8, 2023

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2030

Conditions
Gastric AdenocarcinomaCarcinomatosis
Interventions
DRUG

Paclitaxel

Given by IP (Intraperitoneal injection)

DRUG

Dexamethasone

Given by IV (vein)

DRUG

Diphenhydramine

Given by IV (vein)

DRUG

Famotidine

Given by IV (vein)

Trial Locations (1)

77030

RECRUITING

M D Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER